The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis
Open accessAbstract
BACKGROUND: Based on their capacity to suppress immune responses, multipotent mesenchymal stromal cells (MSC) are intensively studied for various clinical applications. Although it has been shown in vitro that the immunomodulatory effect of MSCs mainly occurs through the secretion of soluble mediators, the mechanism is still not completely understood. The aim of the present study was to better understand the mechanisms underlying the suppressive effect of MSCs in vivo, using cells isolated from mice deficient in the production of inducible nitric oxide synthase (iNOS) or interleukin (IL)-6 in the murine model of collagen-induced arthritis. PRINCIPAL FINDINGS: In the present study, we show that primary murine MSCs from various strains of mice or isolated from mice deficient for iNOS or IL-6 exhibit different immunosuppressive potential. The immunomodulatory function of MSCs was mainly attributed to IL-6-dependent secretion of prostaglandin E2 (PGE2) with a minor role for NO. To address the role of these molecules in vivo, we used the collagen-induced arthritis as an experimental model of immune-mediated disorder. MSCs effectively inhibited collagen-induced inflammation during a narrow therapeutic window. In contrast to wild type MSCs, IL-6-deficient MSCs and to a lesser extent iNOS-deficient MSCs were not able to reduce the clinical signs of arthritis. Finally, we show that, independently of NO or IL-6 secretion or Treg cell induction, MSCs modulate the host response by inducing a switch to a Th2 immune response. SIGNIFICANCE: Our data indicate that mscs mediate their immunosuppressive effect via two modes of action: locally, they reduce inflammation through the secretion of anti-proliferative mediators, such as NO and mainly PGE2, and systemically they switch the host response from a Th1/Th17 towards a Th2 immune profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite
Miranda, K. M., Espey, M. G., & Wink, D. A. (2001) · Nitric Oxide · doi:10.1006/niox.2000.0319 · Cited by 3,860
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364 · cited 2×
“Moreover, MSC-derived PGE2 was reported to act on macrophages, increasing their IL-10 secretion and reducing inflammation [10].”
BackgroundMethodRen, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1496 · Cited by 1,430
Waterman, R. S., Tomchuck, S. L., Henkle, S. L., & Betancourt, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010088 · Cited by 1,238
Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., & Moretta, L. (2008) · Blood · doi:10.1182/blood-2007-02-074997 · Cited by 1,146
Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0554 · Cited by 1,081
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., & Ozawa, K. (2007) · Blood · doi:10.1182/blood-2006-02-002246 · Cited by 954
Nauta, A. J., Kruisselbrink, A. B., Lurvink, E., Willemze, R., & Fibbe, W. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2080 · Cited by 740
Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608249103 · Cited by 710
Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G. A., Willemze, R., & Fibbe, W. E. (2006) · Blood · doi:10.1182/blood-2005-11-011650 · Cited by 694
Spaggiari, G. M., Abdelrazik, H., Becchetti, F., & Moretta, L. (2009) · Blood · doi:10.1182/blood-2009-02-203943 · Cited by 670
Augello, A., Tasso, R., Negrini, S. M., Cancedda, R., & Pennesi, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22511 · Cited by 587
IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
Polchert, D., Sobinsky, J., Douglas, G., Kidd, M., Moadsiri, A., Reina, E., Genrich, K., Mehrotra, S., Setty, S., Smith, B., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200738129 · Cited by 581
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt2 · Cited by 507 · cited 1×
“For instance, it has been shown that murine MSCs do not possess IDO activity, whereas human MSCs are devoid of iNOS (for review, see [11]).”
BackgroundSelf-citationGonzález, M. A., Gonzalez‐Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24405 · Cited by 489
Cartilage engineering: a crucial combination of cells, biomaterials and biofactors
Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., & Noël, D. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.02.005 · Cited by 481
Self-citationGonzalez-Rey, E., Gonzalez, M. A., Varela, N., O'Valle, F., Hernandez-Cortes, P., Rico, L., Büscher, D., & Delgado, M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101881 · Cited by 426
Chan, J. L., Tang, K. C., Patel, A. P., Bonilla, L. M., Pierobon, N., Ponzio, N. M., & Rameshwar, P. (2006) · Blood · doi:10.1182/blood-2006-01-0057 · Cited by 418
Sudres, M., Norol, F., Trenado, A., Grégoire, S., Charlotte, F., Levacher, B., Lataillade, J.-J., Bourin, P., Holy, X., Vernant, J.-P., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7761 · Cited by 413
Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells
Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de vries, R. R. P., & Toes, R. E. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21195 · Cited by 385
Armaka, M., Apostolaki, M., Jacques, P., Kontoyiannis, D. L., Elewaut, D., & Kollias, G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070906 · Cited by 370
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction
Prevosto, C., Zancolli, M., Canevali, P., Zocchi, M. R., & Poggi, A. (2007) · Haematologica · doi:10.3324/haematol.11240 · Cited by 368
Djouad, F., Fritz, V., Apparailly, F., Louis‐Plence, P., Bony, C., Sany, J., Jorgensen, C., & Noël, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21012 · Cited by 352
Self-citationChabannes, D., Hill, M., Merieau, E., Rossignol, J., Brion, R., Soulillou, J. P., Anegon, I., & Cuturi, M. C. (2007) · Blood · doi:10.1182/blood-2007-02-075481 · Cited by 343
Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases
Djouad, F., Bouffi, C., Ghannam, S., Noël, D., & Jorgensen, C. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.104 · Cited by 316
Self-citationVuolteenaho, K., Koskinen, A., Kukkonen, M., Nieminen, R., Päivärinta, U., Moilanen, T., & Moilanen, E. (2009) · Mediators of Inflammation · doi:10.1155/2009/345838 · Cited by 239
Djouad, F., Bony, C., Häupl, T., Uzé, G., Lahlou, N., Louis-Plence, P., Apparailly, F., Canovas, F., Rème, T., Sany, J., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1827 · Cited by 204
Self-citationAdenovirus-Mediated Transfer of Viral IL-10 Gene Inhibits Murine Collagen-Induced Arthritis
Apparailly, F., Verwaerde, C., Jacquet, C., Auriault, C., Sany, J., & Jorgensen, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5213 · Cited by 197
Self-citationCirculating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain
Rummel, C., Sachot, C., Poole, S., & Luheshi, G. N. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00301.2006 · Cited by 179
Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice
Choi, J.-J., Yoo, S.-A., Park, S.-J., Kang, Y.-J., Kim, W.-U., Oh, I.-H., & Cho, C.-S. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03683.x · Cited by 170
Schurgers, E., Kelchtermans, H., Mitera, T., Geboes, L., & Matthys, P. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2939 · Cited by 168
Baboon Mesenchymal Stem Cells Can Be Genetically Modified to Secrete Human Erythropoietin In Vivo
Bartholomew, A., Patil, S., Mackay, A., Nelson, M., Buyaner, D., Hardy, W., Mosca, J., Sturgeon, C., Siatskas, M., Mahmud, N., et al. (2001) · Human Gene Therapy · doi:10.1089/10430340152480258 · Cited by 158
Parekkadan, B., Tilles, A. W., & Yarmush, M. L. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0790 · Cited by 150
Multipotent mesenchymal stromal cells and immune tolerance
Noël, D., Djouad, F., Bouffi, C., Mrugala, D., & Jørgensen, C. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701361869 · Cited by 150
Self-citationMarinova-Mutafchieva, L., Williams, R. O., Funa, N. S., Maini, R. N., & Zvaifler, N. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10126 · Cited by 140
Charbonnier, L., van Duivenvoorde, L. M., Apparailly, F., Cantos, C., Han, W. G. H., Noël, D., Duperray, C., Huizinga, T. W. J., Toes, R. E. M., Jørgensen, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3806 · Cited by 104
Self-citationFlk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6
Chen, B., Hu, J., Liao, L., Sun, Z., Han, Q., Song, Z.-C., & Zhao, R. C. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04069.x · Cited by 89
Role of mesenchymal stromal cells in solid organ transplantation
Hematti, P. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2008.05.002 · Cited by 82
Woolard, M. D., Wilson, J. E., Hensley, L., Jania, L. A., Kawula, T. H., Drake, J. R., & Frelinger, J. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2065 · Cited by 79
Perez, N., Louis‐Plence, P., Millet, V., Greuet, D., Minot, C., Noël, D., Danos, O., Jørgensen, C., & Apparailly, F. (2002) · Human Gene Therapy · doi:10.1089/104303402320987851 · Cited by 75
Self-citationShibata, Y., Henriksen, R. A., Honda, I., Nakamura, R. M., & Myrvik, Q. N. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605321 · Cited by 46
Sawada, T., Falk, L. A., Rao, P., Murphy, W. J., & Pluznik, D. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5267 · Cited by 45
Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells
Son, Y., Ito, T., Ozaki, Y., Tanijiri, T., Yokoi, T., Nakamura, K., Takebayashi, M., Amakawa, R., & Fukuhara, S. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02402.x · Cited by 45
Bour, A. M. J. J., Westendorp, R. G. J., Laterveer, J. C., Bollen, E. L. E. M., & Remarque, E. J. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00128-5 · Cited by 38
Interleukin-1 Inhibits Gamma Interferon-Induced Bacteriostasis in Human Uroepithelial Cells
Däubener, W., Hucke, C., Seidel, K., Hadding, U., & Mackenzie, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5615-5620.1999 · Cited by 30
Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells
Poggi, A. D., & Zocchi, M. R. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.278 · Cited by 17
Cited by
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
Immunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
How mesenchymal stem cells interact with tissue immune responses
Shi, Y., Su, J., Roberts, A. I., Shou, P., Rabson, A. B., & Ren, G. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.11.004 · Cited by 633
Secretion of immunoregulatory cytokines by mesenchymal stem cells
Kyurkchiev, D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.552 · Cited by 617
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders
Riazifar, M., Mohammadi, M. R., Pone, E. J., Yeri, A., Lässer, C., Segaliny, A. I., McIntyre, L. L., Shelke, G. V., Hutchins, E., Hamamoto, A., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01004 · Cited by 551
Metadata
- Authors
- Bouffi, C., Bony, C., Courties, G., Jorgensen, C., & Noël, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e14247
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2140099354
- Cited by
- 383
- References
- 49
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.